Back to catalogue
№ 216 43 filings · 2021-10-13 → 2026-10-09

MJ GLEESON PLC

GLE
Consumer Products and Services Share price 286p Market cap £167m Overall fit 230 /1000

UK low-cost housebuilder with zero AI-receiver exposure (the dominant portfolio pillar) and only moderate operating leverage, but offset by a genuinely cheap valuation (~0.53x tangible NAV) and strong downside protection via a near-debt-free balance sheet. Scores poorly against the strategy because the AI-angle is absent and operating leverage is only moderate, despite the fair-to-cheap price.

Fair value range 275p–375p Mid case · £190m
Absolute upside +13.6% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Audited NAV per share 513p is unambiguous and provides hard book-value floor
  • Near-zero net debt (£2.6m) with £125m undrawn RCF to October 2028
  • Company-compiled FY27 consensus £18.8m PBT disclosed in filings anchors forward earnings
Limits the call
  • Housebuilder cyclicality means NAV multiple and forward earnings both swing with UK rate cycle
  • Pattern of recurring legacy-site and building-safety provisions suggests further one-offs possible
Methodology

Blended NAV multiple (0.55-0.70x) and forward P/E (10-14x FY27 EPS)

In one line · bull case

Debt-free UK affordable housebuilder trading at ~0.53x tangible NAV while mid-cycle through a self-help reset — classic deep-value cyclical with hard book-value floor.

In one line · biggest risk

Margin recovery is slow and open-market reservations remain soft, so NAV re-rating depends on a UK housing cycle inflection that may be years away.

Drivers
AI beneficiary 5 /100
Pure UK affordable housebuilder — zero direct AI exposure or value capture; no addressable market expansion from AI adoption.
Operating leverage 40 /100
Moderate: ~£62m admin / ~£332m COGS at FY26 means volume beats add decent profit but not multi-bagging; variable cost base dominates.
Earnings vs expectations 30 /100
Repeated within-year downgrades in FY25 (June-25 warning) and FY26 (consensus £18.2m in May-26 → delivered £10.8m); more misses than beats in last three years.
Growth momentum 25 /100
Adjusted EPS -51%, PBT -50%, operating profit -37% in FY26; FY27 consensus implies only modest recovery; medium-term 3,000-home target pushed out.
Moat 25 /100
Limited moat — scale and brand in a narrow low-cost niche, but no switching costs, no network effects; land pipeline is replicable.
Earnings quality 45 /100
Recurring exceptional items (restructuring, impairments, legacy-site provisions, building-safety); cash conversion acceptable but reported earnings consistently flattered or hit by one-offs.
Management quality 50 /100
New CEO Prothero (ex-Vistry COO) delivering Project Transform with evident operational grip; dividend policy prudent, but legacy sites continue to generate surprises under new regional teams.
Cyclicality 85 /100
Deeply cyclical UK housebuilder sensitive to mortgage rates, planning policy, consumer confidence and build-cost inflation.
Leverage 20 /100
Fortress balance sheet — £2.6m net debt against £300m equity, £135m RCF with only £10m drawn, extended to Oct 2028.
Value-trap signals · 5
  • Dividend cut from 11.0p to 5.0p (-55%) in FY26
  • Three consecutive years of gross margin compression on homes (24.5% → 20.7% → 18.7%)
  • Repeated within-year guidance downgrades in FY25 and FY26
  • Recurring exceptional charges across multiple years (restructuring, legacy sites, building safety)
  • Planning-system bottlenecks are structural and partly outside management control

MJ Gleeson PLC (GLE) — Investment Research Note

Executive summary

MJ Gleeson is a UK low-cost housebuilder serving first-time buyers in the North of England and Midlands (Gleeson Homes, 98% of revenue) alongside a strategic land-promotion arm in Southern England (Gleeson Land). Across the filings the operating trajectory has deteriorated materially — from FY2022 record adjusted PBT of £55.5m / 2,000 homes, down through FY2023, FY2024 (£25m PBT, 1,772 homes), FY2025 (£21.9m, 1,793 homes) to FY2026 adjusted PBT of £10.8m (statutory loss £2.7m after £13.6m of exceptional restructuring, land impairment and legacy-site adoption provisions), with dividend cut from 11p to 5p and ROCE compressed from 25% to 5.2%. The single most important valuation anchor today is the gap between the share price (270.5p) and audited net asset value per share of 513p — the stock trades at ~0.53x tangible book while the business is going through a self-help ("Project Transform") reset in a subdued housing market.

Fair value estimate

Fair value range: 275p – 375p per share (implied market-cap range £160m – £219m, against current £168m).

Methodology — blended NAV / forward earnings:

  • NAV approach: Audited NAV per share 513p 2026-09 final results. UK listed housebuilder peers trade in a 0.6–1.0x NAV band through-cycle; applying a trough-cycle 0.55x–0.70x reflects below-peer ROCE and operational uncertainty → 282p–359p.
  • Forward P/E: Company-compiled FY2027 consensus adjusted PBT £18.8m 2026-09 final results implies ~£14m PAT and ~24p adjusted EPS; 10x–14x FY27 EPS (reasonable for a housebuilder exiting a down-cycle) → 240p–336p.
  • Mid-cycle sanity check: management's medium-term 3,000-home target at a recovered ~22% gross margin (and ~8% operating margin) implies ~£50–55m operating profit at scale, 65–70p EPS — not required for the central case, but caps upside optionality at 500p+ in a cyclical recovery.

Taking the blended range: midpoint ~325p, mid-mcap ~£189m. Absolute upside from 270.5p: +20% (range: +2% to +39%).

Sector context

Correctly classified as Consumer Discretionary / Consumer Products and Services, specifically UK residential construction. Gleeson's quality (ROCE 5.2%, falling margins), growth (adjusted EPS -51%) and leverage (£2.6m net debt on £300m equity — essentially debt-free) profile is below typical peers on returns and margins, but above peers on balance-sheet strength. Listed comparables: Vistry Group, Persimmon, Bellway, Taylor Wimpey, Barratt Redrow — all materially larger. Closest in positioning (low-end affordable, Midlands/North footprint) is Vistry; among larger peers, Bellway has similar discipline but larger scale. Gleeson is a small-cap outlier with below-peer ROCE but above-peer balance-sheet quality.

Investment thesis

  • Deep discount to tangible NAV with near-zero net debt provides a hard floor. Audited NAV 513p vs. 270.5p share price = 0.53x; £135m undrawn RCF (now extended to Oct 2028), net borrowings only £2.6m, 14,927-plot land pipeline 2026-09 final results. Downside is contained even if the UK housing market stagnates further.
  • Project Transform structural reset has been expensed; the exceptional run is largely behind. £13.6m of FY26 exceptionals absorbed (£2.0m restructuring, £4.5m WIP impairment, £7.1m legacy-site adoption provision) and the business delivered a 9.8% volume uplift to 1,968 homes with 8 new partnership agreements signed 2026-09 final results, 2026-07 trading update. Annualised cost savings of ~£2m from restructuring will carry forward.
  • Partnerships model opens a capital-light growth channel aligned to UK government policy. First partnership completions delivered 320 units in FY26 (nil in FY25), with 11 sites in development and clear tailwind from the Government's £39bn Social & Affordable Homes Programme 2026-02 interim results, 2026-09 final results. Capital-light forward funding improves returns at the margin and reduces working-capital risk — the right strategic direction given the business's exposure to subdued open-market demand.

Key risks

  • Margin recovery is slow and uncertain. Build cost inflation (4.5% in FY26) continues to outpace selling-price increases (3.0% underlying); gross margin on homes compressed to 18.7% from 20.7% and management explicitly warned the FY27 pace of margin recovery will be slow due to "continuing regulatory and tax burdens" 2026-09 final results. FY27 consensus assumes only partial recovery.
  • Open-market reservation trajectory is still soft. H1 FY27 open-market net reservation rate 0.44 per site per week (vs. 0.55 prior year); the business is explicitly operating from fewer sites in FY27 and FY28 than previously planned due to planning bottlenecks and portfolio rationalisation 2026-09 final results.
  • Legacy fire-safety and site-adoption liabilities continue to accrete. £11.3m building-safety provision ongoing (18 buildings over 11m, 2 completed/in sign-off), plus new £7.1m legacy site-adoption provision in FY26 for roads/services on previously completed developments 2026-09 final results. Pattern of recurring "new" legacy issues identified by new management teams raises the risk of further provisions.

Operating leverage

Gleeson has moderate, not high, operating leverage. The cost base is dominated by variable inputs: cost of sales was £332m against revenue of £410m in FY26 (~81% of revenue), with build cost inflation flowing almost directly into margin 2026-09 final results. Administrative expenses of £62.0m represent the fixed element — roughly 15% of revenue — and management confirmed in the FY25 restructuring that total annualised cost savings were only ~£3-4m from reorganising nine regions into six. Gross margin at 18.7% (homes) with central overhead ~£3.4m is relatively low: a 10% volume beat would plausibly add ~£7-8m of gross profit against unchanged overhead, i.e. ~70% uplift to the £10.8m adjusted PBT. A 20% volume beat → ~140% operating profit uplift. This is meaningful but not multi-bagging operating leverage — closer to a cyclical housebuilder than a software platform. The partnerships model is capital-light but low-margin, and Gleeson Land is lumpy (one site deferred into FY27 flipped the division from £7.0m profit to £0.7m loss). The fixed-cost base simply isn't large enough relative to variable costs to produce "percentage revenue beats become multiples of profit" dynamics the strategy ideally wants.

Value-trap signals

  • Dividend cut from 11.0p to 5.0p (-55%) in FY26, framed as "prudent" but still a signal.
  • Three consecutive years of margin compression (28.5% → 24.5% → 20.7% → 18.7% gross margin on homes).
  • Repeated downgrades to full-year guidance within fiscal years (FY25 PBT consensus £24.5m in Jul-24 → ~£22m → delivered £21.9m; FY26 consensus £18.2m in May-26 → delivered £10.8m).
  • Recurring exceptional charges (restructuring in FY25 and FY26, legacy-site provisions in FY26, building-safety provision in FY22).
  • Planning-system constraints are structural and partly outside management control.
  • Mitigating: no customer concentration, no related-party concerns (Harwood Property transaction £6.5m is small and disclosed), no going-concern issues, debt-free balance sheet, no revenue decline.

Not a terminal-decline situation — the industry is cyclical rather than structurally challenged — but the signals point to a value stock requiring patience and a cyclical recovery to re-rate.

Earnings vs. expectations

  • FY2022 (Sep-22): Delivered 2,000 homes target, adjusted PBT £55.5m vs. ~£42m peer consensus — material beat.
  • FY2023 (Sep-23): Volumes 1,723 (vs. 2,000 prior year), PBT £31.5m adjusted — in line with downgraded expectations after mid-year warning.
  • FY2024 (Sep-24): Pre-close trading update 11 Jul 24 flagged Gleeson Homes "ahead of expectations" and Gleeson Land "below"; net result broadly in line.
  • FY2025 (Sep-25): June 3 2025 profit warning — Gleeson Homes operating profit "circa 15-20% below current expectations" after a key East Yorkshire land sale fell through; final result adjusted PBT £21.9m — a miss vs. earlier expectations.
  • FY2026 (Sep-26): Interim guidance ratcheted down from £18.2m consensus (May-26) to £10.1m (Jul-26 trading update); final delivery £10.8m vs. revised £10.1m — technically met the final-revised bar but overall year was a material miss vs. year-start expectations.

Pattern: more misses than beats in the past three years, with repeated within-year guidance resets.

Conviction

Conviction: 3 — moderate.

Anchors (support the FV call): (i) audited NAV is unambiguous and the balance sheet is almost debt-free, giving a hard floor; (ii) peer group of UK housebuilders is well-covered and the NAV-multiple framework is standard sector methodology; (iii) company-compiled FY27 consensus is disclosed in the filings themselves 2026-09 final results, providing a direct earnings anchor.

Limiters: (i) housebuilder cyclicality means NAV and forward earnings can both shift materially with mortgage rates and planning policy — a 10% move in either moves fair value meaningfully; (ii) ongoing legacy-site and building-safety provisions suggest further one-offs cannot be ruled out, which would erode NAV.


Filings consulted · 43

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-10-09Notice OF Agm2026-10-09_9814561_notice-of-agm.md0.30
  2. 2026-09-15Final Results2026-09-15_9771574_final-results.md1.00
  3. 2026-09-14Engage Investor Presentation2026-09-14_9770838_engage-investor-presentation.md0.70
  4. 2026-07-10Trading Statement2026-07-10_9661984_trading-statement.md0.85
  5. 2026-05-01Trading Update2026-05-01_9547950_trading-update.md0.85
  6. 2026-04-23Notice OF Trading Updates And Fy2026 Results2026-04-23_9533782_notice-of-trading-updates-and-fy2026-results.md0.85
  7. 2026-02-11Results For The Half Year Ended 31 December 20252026-02-11_9424662_results-for-the-half-year-ended-31-december-2025.md0.77
  8. 2026-02-09Presentation OF HY Results ON Engage Investor2026-02-09_9420133_presentation-of-hy-results-on-engage-investor.md0.59
  9. 2026-01-16Trading Update And Notice OF Results2026-01-16_9357547_trading-update-and-notice-of-results.md0.72
  10. 2025-11-14Result OF Agm2025-11-14_9234857_result-of-agm.md0.26
  11. 2025-11-14Agm Trading Update2025-11-14_9232963_agm-trading-update.md0.72
  12. 2025-10-17Notice OF Agm2025-10-17_9176892_notice-of-agm.md0.26
  13. 2025-09-18Presentation ON Engage Investor Platform2025-09-18_9115280_presentation-on-engage-investor-platform.md0.46
  14. 2025-08-13Notice OF Full Year Results And Presentation2025-08-13_9048706_notice-of-full-year-results-and-presentation.md0.65
  15. 2025-07-04Trading Statement2025-07-04_8963343_trading-statement.md0.55
  16. 2025-06-03Trading Update2025-06-03_8909032_trading-update.md0.55
  17. 2025-02-11Results For The Half Year Ended 31 December 20242025-02-11_8730268_results-for-the-half-year-ended-31-december-2024.md0.58
  18. 2025-01-14Trading Update Amp Notice OF Results2025-01-14_8686459_trading-update-amp-notice-of-results.md0.55
  19. 2024-11-15Result OF Agm2024-11-15_8553464_result-of-agm.md0.20
  20. 2024-11-15Agm Trading Update2024-11-15_8551567_agm-trading-update.md0.55
  21. 2024-10-21Notice OF Agm2024-10-21_8497381_notice-of-agm.md0.20
  22. 2024-07-11Fy2024 Trading Update2024-07-11_8305222_fy2024-trading-update.md0.38
  23. 2024-07-08Notice OF Trading Update2024-07-08_8298019_notice-of-trading-update.md0.38
  24. 2024-02-15Results For The Half Year Ended 31 December 20232024-02-15_8038807_results-for-the-half-year-ended-31-december-2023.md0.41
  25. 2024-01-09Trading Update Amp Notice OF Results2024-01-09_7980186_trading-update-amp-notice-of-results.md0.38
  26. 2023-11-16Result OF Agm2023-11-16_7886137_result-of-agm.md0.14
  27. 2023-11-16Agm Trading Update2023-11-16_7884397_agm-trading-update.md0.38
  28. 2023-10-17Notice OF Agm2023-10-17_7820356_notice-of-agm.md0.14
  29. 2023-07-07Trading Update And Capital Markets Day2023-07-07_7618152_trading-update-and-capital-markets-day.md0.24
  30. 2023-03-21Notice OF Capital Markets Day And Trading Update2023-03-21_7479853_notice-of-capital-markets-day-and-trading-update.md0.24
  31. 2023-02-16Results For The Half Year Ended 31 December 20222023-02-16_7482090_results-for-the-half-year-ended-31-december-2022.md0.23
  32. 2023-01-13Trading Update Amp Notice OF Results2023-01-13_7399280_trading-update-amp-notice-of-results.md0.21
  33. 2022-11-18Result OF Agm2022-11-18_7417629_result-of-agm.md0.07
  34. 2022-11-18Agm Trading Update2022-11-18_7414752_agm-trading-update.md0.21
  35. 2022-10-20Notice OF Agm2022-10-20_7385256_notice-of-agm.md0.07
  36. 2022-09-15Final Results2022-09-15_7316190_final-results.md0.25
  37. 2022-07-11Trading Update Amp Notice OF Results2022-07-11_6923332_trading-update-amp-notice-of-results.md0.21
  38. 2022-05-12Notice OF Trading Update Amp Results2022-05-12_7275067_notice-of-trading-update-amp-results.md0.21
  39. 2022-02-10Half Year Report2022-02-10_6800446_half-year-report.md0.23
  40. 2022-01-11Notice OF Results Amp Trading Update2022-01-11_6807772_notice-of-results-amp-trading-update.md0.21
  41. 2021-11-15Result OF Agm2021-11-15_6738878_result-of-agm.md0.07
  42. 2021-11-15Agm Statement2021-11-15_6737702_agm-statement.md0.10
  43. 2021-10-13Notice OF Agm2021-10-13_6768774_notice-of-agm.md0.07

This research note was authored by a large language model after reading 43 regulatory filings published between 2021-10-13 and 2026-10-09. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.